Authors
Nicholas L Rider
Published in
Immunology and allergy clinics of North America. Volume 47. Issue 1. Pages 115-130. Epub Sep 17, 2026.
Abstract
This article examines the expanding role of population-level data and computational approaches within Allergy-Immunology. Rising prevalence, multimorbidity, and heterogeneity across allergic and immune-mediated diseases necessitate approaches beyond clinical trials. Leveraging electronic health records, claims data, registries, environmental data, and multiomics platforms enables refined epidemiology, phenotyping, comparative effectiveness research, and evaluation of social and environmental determinants. These tools support precision medicine and value-based care while illuminating disparities. However, data quality, algorithmic bias, interoperability limitations, analytical complexity, and ethical concerns pose sobering challenges. Rigorous governance, equity-centered implementation, and sustained methodological oversight are essential to responsibly translate real-world data into improved patient outcomes.
PMID:
43045418
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0